Cancer Cells Responsible for Humoral Hypercalcemia Express mRNA Encoding a Secreted Form of ODF/TRANCE That Induces Osteoclast Formation

This publication has 32 references indexed in Scilit:

• STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone
  Journal of Biological Chemistry, 1999
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
  Journal of Clinical Investigation, 1999
• RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
  Biochemical and Biophysical Research Communications, 1998
• Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
  Cell, 1998
• Fatal parathyroid hormone-related protein-induced humoral hypercalcemia of malignancy in a 3-month-old infant
  European Journal of Pediatrics, 1994
• Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on bone resorption and formation in organ culture
  Bone, 1993
• Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts
  Journal of Bone and Mineral Research, 1991
• Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy
  Journal of Bone and Mineral Research, 1989
• EXPRESSION OF PARATHYROID HORMONE-RELATED PROTEIN mRNA IN TUMORS OBTAINED FROM PATIENTS WITH HUMORAL HYPERCALCEMIA OF MALIGNANCY
  Japanese Journal of Cancer Research, 1988
• Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
  Journal of Clinical Investigation, 1986